Positive opinion for Novo Nordisk’s Sogroya by John Pinching | May 26, 2023 | News | 0 Therapy has been developed for use among children and adolescents with growth hormone deficiency Read More
Positive Phase I results for Allergy’s Acarovac by Anna Smith | May 21, 2019 | News | 0 Good news for patients with house dust mite-induced allergic rhinoconjunctivitis. Read More